Mild ERCP-induced and non-ERCP-related acute pancreatitis: Two distinct clinical entities?

Journal of Gastroenterology

Volumn 42, Issue 2, 2007, Pages 146-151

  Abid, Ghalib H ^a   Siriwardana, H Priyantha ^a   Holt, Adrian ^a   Ammori, Basil J ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Amylase; ERCP; Pain; Pancreatitis; Severity

Indexed keywords

ANALGESIC AGENT; MORPHINE; NARCOTIC ANALGESIC AGENT;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERAMYLASEMIA; HYPOTHESIS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REHYDRATION; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; AGED; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33947172722     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-006-1979-7     Document Type: Article

References (25)

1. A Mariani 2003 Pharmacological prevention of post-ERCP pancreatitis: which therapy is best? JOP 4 68-74 12555018
2. AS Fung GG Tsiotos MG Sarr 1997 ERCP-induced acute necrotizing pancreatitis: Is it a more severe disease? Pancreas 15 217-21 9336783 10.1097/00006676-199710000-00001 1:STN:280:ByiH2sjosFQ%3D
3. EL Bradley III 1993 A clinically based classification system for acute pancreatitis Arch Surg 128 586-90 8489394
4. JH Robert JL Frossard B Mermillod C Soravia N Mensi M Roth 2002 Early prediction of acute pancreatitis: Prospective study comparing computed tomography scans, Ranson, Glasgow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers World J Surg 26 612-9 12098056 10.1007/s00268-001-0278-y
5. AA Khan D Parekh Y Cho R Ruiz RR Selby N Jabbour et al 2002 Improved prediction of outcome in patients with severe acute pancreatitis by the APACHE II score at 48 hours after hospital admission compared with the APACHE II score at admission. Acute Physiology and Chronic Health Evaluation Arch Surg 137 1136-40 12361419 10.1001/archsurg.137.10.1136
6. PB Cotton G Lehman J Vennes JE Geenen RC Russell WC Meyers et al 1991 Endoscopic sphincterotomy complications and their management: An attempt at consensus Gastrointest Endosc 37 383-93 2070995 1:STN:280:By6A3c7kt1M%3D
7. RT Poon C Yeung CM Lo WK Yuen CL Liu ST Fan 1999 Prophylactic effect of somatostatin on post-ERCP pancreatitis: A randomized controlled trial Gastrointest Endosc 49 593-8 10228257 10.1016/S0016-5107(99)70387-1 1:STN:280:DyaK1M3ks1aqtA%3D%3D
8. PD Hardt O Kress T Fadgyas W Doppl H Schnell-Kretschmer O Wusten 2000 Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy Eur J Med Res 5 165-70 10799351 1:CAS:528:DC%2BD3cXjtlKku7w%3D
9. RT Poon C Yeung CL Liu CM Lam WK Yuen CM Lo 2003 Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: A randomised controlled trial Gut 52 1768-73 14633959 10.1136/gut.52.12.1768 1:CAS:528:DC%2BD2cXhtlSgug%3D%3D
10. B Murray R Carter C Imrie S Evans C O'Suilleabhain 2003 Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography Gastroenterology 124 1786-91 12806612 10.1016/ S0016-5085(03)00384-6 1:CAS:528:DC%2BD3sXlt1yrt7c%3D
11. G Cavallini A Tittobello L Frulloni E Masci A Mariana V Di Francesco 1996 Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy: Italian Group N Engl J Med 335 919-23 8786777 10.1056/ NEJM199609263351302 1:CAS:528:DyaK28Xmt1Kju7Y%3D
12. PA Testoni S Caporuscio F Bagnolo F Lella 1999 Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy Endoscopy 31 131-6 10223361 10.1055/s-1999-13660 1:STN:280:DyaK1M3jslyksA%3D%3D
13. K Gottlieb S Sherman 1998 ERCP and biliary endoscopic sphincterotomy-induced pancreatitis Gastrointest Endosc Clin N Am 8 87-114 9405753 1:STN:280:DyaK1c%2FntVyksg%3D%3D
14. G de Palma C Catanzano 1999 Use of corticosteroids in the prevention of post-ERCP pancreatitis: Results of a controlled prospective study Am J Gastroenterol 94 982-5 10201469 10.1111/j.1572-0241.1999.999_u.x 1:CAS:528:DyaK1MXisVOltLg%3D
15. A Budzynska T Marek A Nowak R Kaczor E Nowakowska-Dulawa 2001 A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis Endoscopy 33 766-72 11558030 10.1055/s-2001-16520 1:STN:280:DC%2BD3MrgvFeqsQ%3D%3D
16. A Andriulli R Clemente L Solmi V Terruzzi R Suriani A Sigillito 2002 Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: A multicenter, placebo-controlled, randomized clinical trial Gastrointest Endosc 56 488-95 12297762 10.1016/ S0016-5107(02)70431-8
17. E Masci G Cavallini A Mariani L Frulloni PA Testoni S Curioni 2003 Gabexate in Digestive Endoscopy-Italian Group II. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis Am J Gastroenterol 98 2182-6 14572565 10.1111/j.1572-0241.2003.07698.x 1:CAS:528:DC%2BD3sXot12itrc%3D
18. KF Binmoeller AG Harris R Dumas C Grimaldi JP Delmont 1992 Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis? Gut 33 1129-33 1383099 1:STN:280:ByyD3Mzhs1Y%3D
19. R Arcidiacono P Gambitta A Rossi C Grosso M Bini G Zanasi 1994 The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy Endoscopy 26 715-8 7536155 1:STN:280:ByqB38flslY%3D
20. JM Bordas V Toledo-Pimentel J Llach M Elena F Mondelo A Gines 1998 Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: Results of a randomized study Gastrointest Endosc 47 230-4 9540874 10.1016/S0016-5107(98)70318-9 1:STN:280:DyaK1c7pvF2nsA%3D%3D
21. J Deviere O Le Moine JL van Laethem P Eisendrath A Ghilain N Severs et al 2001 Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography Gastroenterology 120 498-505 11159890 10.1053/gast.2001.21172 1:CAS:528:DC%2BD3MXhtlKltbw%3D
22. PA Testoni F Bagnolo A Andriulli G Bernasconi S Crotta F Lella et al 2001 Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: Results of a multicenter, randomized, controlled trial Aliment Pharmacol Ther 15 965-72 11421871 10.1046/ j.1365-2036.2001.01015.x 1:CAS:528:DC%2BD3MXltFWqs7k%3D
23. S Manolakopoulos A Avgerinos J Vlachogiannakos A Armonis N Viazis N Papadimitriou et al 2002 Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: A multicenter randomized controlled trial Gastrointest Endosc 55 470-5 11923756 10.1067/ mge.2002.122614
24. F Prat J Amaris B Ducot M Bocquentin J Fritsch AD Choury et al 2002 Nifedipine for prevention of post-ERCP pancreatitis: A prospective, double-blind randomized study Gastrointest Endosc 56 202-8 12145597 10.1016/S0016-5107(02)70178-8
25. J Baillie 2002 Predicting and preventing post-ERCP pancreatitis Curr Gastroenterol Rep 4 112-9 11900675